Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  

  FDsys > More Information
(Search string is required)

16-11992 - Doshi v. Tokai Pharmaceuticals, Inc. et al

Download Files


Document in Context
16-11992 - Doshi v. Tokai Pharmaceuticals, Inc. et al
March 16, 2018
PDF | More
Judge Mark L. Wolf: "...V. ORDER 1. Garbowski, Buchansky, Doshi, and Purohit shall each, by April 20, 2018, either: (a) move, individually or as a group, to be appointed lead plaintiff and propose class counsel; or (b) state that he does not seek to serve as lead plaintiff. If they wish to apply for appointment as a group, they shall address the factors discussed in In re Cendant Corp., 264 F. 3d at 266-67. 2. A hearing shall be held on April 30, 2018, at 2:00 p.m. Any person seeking to serve as lead plaintiff shall attend and be prepared to testify if necessary." ORDER entered. MEMORANDUM AND ORDER. Associated Cases: 1:16-cv-11963-MLW, 1:16-cv-11992-MLW(Bono, Christine)